Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
6.79
-0.28 (-3.96%)
At close: Jul 15, 2025, 4:00 PM
6.78
-0.01 (-0.15%)
After-hours: Jul 15, 2025, 4:00 PM EDT
Exagen Stock Forecast
Stock Price Forecast
The 2 analysts that cover Exagen stock have a consensus rating of "Strong Buy" and an average price target of $7.5, which forecasts a 10.46% increase in the stock price over the next year. The lowest target is $7 and the highest is $8.
Price Target: $7.5 (+10.46%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2025.
Analyst Ratings
The average analyst rating for Exagen stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +3.09% | May 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +17.82% | May 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | +17.82% | Jan 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +3.09% | Jan 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +3.09% | May 14, 2024 |
Financial Forecast
Revenue This Year
66.17M
from 55.64M
Increased by 18.92%
Revenue Next Year
75.95M
from 66.17M
Increased by 14.78%
EPS This Year
-0.57
from -0.83
EPS Next Year
-0.23
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.4M | 81.5M | 89.7M | ||
| Avg | 66.2M | 76.0M | 85.5M | ||
| Low | 62.6M | 72.5M | 82.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.4% | 23.1% | 18.1% | ||
| Avg | 18.9% | 14.8% | 12.6% | ||
| Low | 12.5% | 9.6% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.56 | -0.08 | -0.12 | ||
| Avg | -0.57 | -0.23 | -0.11 | ||
| Low | -0.60 | -0.30 | -0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.